HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Claude Trinchet Selected Research

Neoplasms (Cancer)

1/2016Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results.
1/2016Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.
12/2013ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
8/2013Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.
4/2013Diaphragmatic necrosis after radiofrequency ablation of hepatocellular carcinoma: a successful surgical repair.
5/2007Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
7/2005Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
1/2005Local/regional and systemic treatments of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Claude Trinchet Research Topics

Disease

30Hepatocellular Carcinoma (Hepatoma)
01/2016 - 06/2002
24Fibrosis (Cirrhosis)
01/2016 - 12/2002
8Neoplasms (Cancer)
01/2016 - 01/2005
8Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
08/2013 - 03/2005
6Hepatitis C
08/2012 - 03/2004
5Liver Diseases (Liver Disease)
02/2015 - 05/2007
3Necrosis
03/2015 - 01/2005
2Ascites
02/2015 - 02/2005
2Carcinogenesis
08/2013 - 07/2010
2Insulin Resistance
08/2011 - 11/2010
2Iron Overload
01/2008 - 05/2007
2Infections
05/2007 - 03/2004
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2006 - 01/2005
1Hemorrhage
02/2015
1Hepatic Encephalopathy
02/2015
1Esophageal and Gastric Varices (Esophageal Varices)
02/2015
1Disease Progression
02/2015
1Inflammation (Inflammations)
01/2015
1Acute-On-Chronic Liver Failure
01/2014
1Wounds and Injuries (Trauma)
04/2013
1Liver Abscess
04/2013
1HIV Infections (HIV Infection)
06/2012
1Liver Neoplasms (Liver Cancer)
06/2012
1Type 2 Diabetes Mellitus (MODY)
08/2011
1Hemochromatosis (Bronze Diabetes)
07/2011
1End Stage Liver Disease
07/2011
1Obesity
11/2010
1Persistent Infection
11/2010
1Cholestasis
07/2008

Drug/Important Bio-Agent (IBA)

6IronIBA
01/2015 - 03/2006
4Biomarkers (Surrogate Marker)IBA
01/2016 - 08/2013
4Antiviral Agents (Antivirals)IBA
06/2014 - 02/2005
3Biological ProductsIBA
01/2015 - 12/2006
3Ethanol (Ethyl Alcohol)IBA
01/2015 - 12/2002
3AntioxidantsIBA
08/2012 - 03/2006
3Peroxidase (Myeloperoxidase)IBA
02/2012 - 11/2009
3ChemokinesIBA
07/2011 - 05/2007
3Chemokine CCL5IBA
07/2011 - 05/2007
3Superoxide DismutaseIBA
11/2008 - 03/2005
2CreatinineIBA
02/2015 - 01/2014
2Serum AlbuminIBA
02/2015 - 04/2005
2LipidsIBA
01/2015 - 12/2012
2Glutamine (L-Glutamine)FDA Link
01/2014 - 12/2012
2Protons (Proton)IBA
01/2014 - 12/2012
2Insulin-Like PeptidesIBA
08/2012 - 09/2008
2EnzymesIBA
07/2011 - 03/2006
2superoxide dismutase 2IBA
07/2011 - 11/2009
2Genetic Markers (Genetic Marker)IBA
02/2008 - 05/2007
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2008 - 05/2007
2Chemokine ReceptorsIBA
02/2008 - 05/2007
2InterferonsIBA
11/2007 - 03/2004
1Proteins (Proteins, Gene)FDA Link
01/2016
1F 4 (F-4)IBA
11/2015
1Keratin-18 (Keratin 18)IBA
03/2015
1Sorafenib (BAY 43-9006)FDA Link
03/2015
1AlbuminsIBA
02/2015
1Prothrombin (Factor II)IBA
02/2015
1BilirubinIBA
02/2015
1YttriumIBA
01/2015
1Fetal Proteins (Fetoprotein)IBA
10/2014
1Interleukin-6 (Interleukin 6)IBA
08/2014
1CytokinesIBA
08/2014
1Lactic Acid (Lactate)FDA LinkGeneric
01/2014
1Pyruvic Acid (Pyruvate)IBA
01/2014
1Phenylalanine (L-Phenylalanine)FDA Link
01/2014
1Ketone BodiesIBA
01/2014
1Tyrosine (L-Tyrosine)FDA Link
01/2014
1CateninsIBA
12/2013
1Epithelial Cell Adhesion MoleculeIBA
12/2013
1GlypicansIBA
08/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013
1Syndecan-1 (Syndecan 1)IBA
08/2013
1Proteoglycans (Proteoglycan)IBA
08/2013
1Glycoproteins (Glycoprotein)IBA
12/2012
1Glutamic Acid (Glutamate)FDA Link
12/2012
1Acetates (Acetic Acid Esters)FDA Link
12/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1Propranolol (Inderal)FDA LinkGeneric
08/2012
1sodium bisulfiteFDA Link
08/2012
1Metformin (Glucophage)FDA LinkGeneric
08/2011
1alanylprolineIBA
07/2011
1AdiponectinIBA
11/2010
1LeptinIBA
11/2010
1Keratins (Keratin)IBA
07/2010
1Adenosine Triphosphate (ATP)IBA
07/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2008
1Ribavirin (Virazole)FDA LinkGeneric
11/2007
1Interferon-alpha (Interferon Alfa)IBA
11/2007
1Chemokine CXCL12IBA
05/2007
1CCR ReceptorsIBA
05/2007
1CCR2 ReceptorsIBA
05/2007
1AntibodiesIBA
03/2006
1prolylleucineIBA
03/2006

Therapy/Procedure

8Radiofrequency Ablation
01/2016 - 07/2005
5Therapeutics
06/2014 - 01/2005
3Transplantation
08/2011 - 06/2002
1Electrodes (Electrode)
01/2016
1Sphincterotomy
04/2013
1Highly Active Antiretroviral Therapy (HAART)
06/2012
1Contraindications
08/2011